Clinical trial

Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function

NCT00626249

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-08-01

PhasePHASE1

Study timeline

Study start (unknown)2007-08-01Date precision: month

Registry last updated2013-12-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mild Nephropathyunresolved

Moderate Nephropathyunresolved

Diabetes Mellitusunresolved

Interventions

Technosphere Inhalation PowderDRUG

Sponsors & collaborators

Mannkind Corporationlead sponsor

Mapped research locations

San AntonioTexas, United States1 MinneapolisMinnesota, United States1 OmahaNebraska, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00626249 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.